These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

730 related items for PubMed ID: 20107302

  • 1. Review of medication adherence in children and adults with ADHD.
    Adler LD, Nierenberg AA.
    Postgrad Med; 2010 Jan; 122(1):184-91. PubMed ID: 20107302
    [Abstract] [Full Text] [Related]

  • 2. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA, Pliszka SR.
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [Abstract] [Full Text] [Related]

  • 3. Improving psychostimulant adherence in children with ADHD.
    Charach A, Gajaria A.
    Expert Rev Neurother; 2008 Oct; 8(10):1563-71. PubMed ID: 18928348
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population.
    Christensen L, Sasané R, Hodgkins P, Harley C, Tetali S.
    Curr Med Res Opin; 2010 Apr; 26(4):977-89. PubMed ID: 20178404
    [Abstract] [Full Text] [Related]

  • 5. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
    Winterstein AG, Gerhard T, Shuster J, Zito J, Johnson M, Liu H, Saidi A.
    Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
    [Abstract] [Full Text] [Related]

  • 6. ADHD medication use, adherence, persistence and cost among Texas Medicaid children.
    Barner JC, Khoza S, Oladapo A.
    Curr Med Res Opin; 2011 Jan; 27 Suppl 2():13-22. PubMed ID: 21973228
    [Abstract] [Full Text] [Related]

  • 7. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
    Findling RL.
    Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
    [Abstract] [Full Text] [Related]

  • 8. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ, Baird G, Pityaratstian N, Tavare E, Gringras P.
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [Abstract] [Full Text] [Related]

  • 9. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
    Yang P, Hsu HY, Chiou SS, Chao MC.
    Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Parental angst making and revisiting decisions about treatment of attention-deficit/hyperactivity disorder.
    Brinkman WB, Sherman SN, Zmitrovich AR, Visscher MO, Crosby LE, Phelan KJ, Donovan EF.
    Pediatrics; 2009 Aug; 124(2):580-9. PubMed ID: 19651580
    [Abstract] [Full Text] [Related]

  • 12. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B, Sopko MA, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT.
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
    Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, Pierce K, Wolraich ML, American Academy of Pediatrics Committee on Quality Improvement, American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder.
    Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
    [Abstract] [Full Text] [Related]

  • 16. Treatment outcomes with methylphenidate formulations among patients with ADHD: retrospective claims analysis of a managed care population.
    Hodgkins P, Sasané R, Christensen L, Harley C, Liu F.
    Curr Med Res Opin; 2011 Jun; 27 Suppl 2():53-62. PubMed ID: 21973231
    [Abstract] [Full Text] [Related]

  • 17. Utilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analysis of data from the Texas Medicaid program.
    Lawson KA, Johnsrud M, Hodgkins P, Sasané R, Crismon ML.
    Clin Ther; 2012 Apr; 34(4):944-956.e4. PubMed ID: 22444786
    [Abstract] [Full Text] [Related]

  • 18. Medication adherence and symptom reduction in adults treated with mixed amphetamine salts in a randomized crossover study.
    Adler LA, Lynch LR, Shaw DM, Wallace SP, Ciranni MA, Briggie AM, Kulaga A, O'Donnell KE, Faraone SV.
    Postgrad Med; 2011 Sep; 123(5):71-9. PubMed ID: 21904088
    [Abstract] [Full Text] [Related]

  • 19. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.
    Carpentier PJ, de Jong CA, Dijkstra BA, Verbrugge CA, Krabbe PF.
    Addiction; 2005 Dec; 100(12):1868-74. PubMed ID: 16367988
    [Abstract] [Full Text] [Related]

  • 20. Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2005 Sep 02; 54(34):842-7. PubMed ID: 16138075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.